Abstract:Background: Inflammation plays a critical role in tumor development. Inflammatory cell infiltration and inflammatory mediator synthesis cause changes in the tumor microenvironment (TME) in several cancers, especially in intrahepatic cholangiocellular carcinoma (ICC). However, methods to ascertain the inflammatory state of patients using reliable biomarkers are still being explored. Method: We retrieved the RNA sequencing and somatic mutation analyses results and the clinical characteristics of 244 patients with ICC from published studies. We performed consensus clustering to identify the molecular subtypes associated with inflammation. We compared the prognostic patterns, clinical characteristics, somatic mutation profiles, and immune cell infiltration patterns across inflammatory subtypes. We performed quantitative real-time polymerase chain reaction (qRT-PCR) and immunohistochemistry (IHC) to confirm gene expression. We performed logistic regression analyses to construct a nomogram predicting the inflammatory status of patients with ICC. Results: Our results confirmed that ICC can be categorized into an inflammation-high subtype (IHS) and an inflammation-low subtype (ILS). Patients from each group had distinct prognosis, clinical characteristics, and TME composition. Patients with ICC in the IHS group showed poorer prognosis owing to the immunosuppressive microenvironment and high frequency of KRAS and TP53 mutations. Cancer-associated fibroblast (CAF)-derived COLEC11 reduced myeloid inflammatory cell infiltration and attenuated inflammatory responses. The results of qRT-PCR and IHC experiments confirmed that COLEC11 expression levels were significantly reduced in tumor tissues compared to those in paracancerous tissues. Patients with ICC in the IHS group were more likely to respond to treatment with immune checkpoint inhibitors (ICIs) owing to their higher tumor mutational burden (TMB) scores, tumor neoantigen burden (TNB) scores, neoantigen counts, and immune checkpoint expression levels. Finally, we developed a nomogram to effectively predict the inflammatory status of patients with ICC based on their clinical characteristics and inflammatory gene expression levels. We evaluated the calibration, discrimination potential, and clinical utility of the nomogram. Conclusion: The inflammatory response in IHS is primarily induced by myeloid cells. COLEC11 can reduce the infiltration level of this group of cells, and myeloid inflammatory cells may be a novel target for ICC treatment. We developed a novel nomogram that could effectively predict the inflammatory state of patients with ICC, which will be useful for guiding individualized treatment plans.

Identification of Biomarkers of Intrahepatic Cholangiocarcinoma Via Integrated Analysis of Mrna and Mirna Microarray Data.

Integration Analysis of Mirna–mrna Expression Exploring Their Potential Roles in Intrahepatic Cholangiocarcinoma

Integrative Analysis of Cerna Network Reveals Functional Lncrnas in Intrahepatic Cholangiocarcinoma

Identification of the typical miRNAs and target genes in hepatocellular carcinoma.

Selecting Molecular Therapeutic Drug Targets Based on the Expression Profiles of Intrahepatic Cholangiocarcinomas and Mirna-Mrna Regulatory Networks

Identification of a Novel Microrna Signature Associated with Intrahepatic Cholangiocarcinoma (ICC) Patient Prognosis

Integrated Mrna and Lncrna Expression Profiling for Exploring Metastatic Biomarkers of Human Intrahepatic Cholangiocarcinoma.

The Role of Microrna Expression Pattern in Human Intrahepatic Cholangiocarcinoma

Transcriptomic Profiling Reveals Hepatic Stem-Like Gene Signatures and Interplay of Mir-200C and Epithelial-Mesenchymal Transition in Intrahepatic Cholangiocarcinoma.

Differentially Expressed Gene Profiles of Intrahepatic Cholangiocarcinoma, Hepatocellular Carcinoma, and Combined Hepatocellular-Cholangiocarcinoma by Integrated Microarray Analysis

Coding-noncoding Gene Expression in Intrahepatic Cholangiocarcinoma.

Computational Recognition and Clinical Verification of TGF-β-Derived miRNA Signature With Potential Implications in Prognosis and Immunotherapy of Intrahepatic Cholangiocarcinoma

Upregulated Circulating Mir-150 is Associated with the Risk of Intrahepatic Cholangiocarcinoma

CeRNA Regulatory Network-Based Analysis to Study the Roles of Noncoding RNAs in the Pathogenesis of Intrahepatic Cholangiocellular Carcinoma

Identification of macrophage correlated biomarkers to predict the prognosis in patients with intrahepatic cholangiocarcinoma

Identification and validation of inflammatory subtypes in intrahepatic cholangiocellular carcinoma

Identification of Potential Prognostic Long Non-Coding RNA for Predicting Survival in Intrahepatic Cholangiocarcinoma.

Profiling and Integrated Analysis of Differentially Expressed MicroRNAs as Novel Biomarkers of Hepatocellular Carcinoma

In Silico Analysis Excavates Potential Biomarkers by Constructing Mirna-Mrna Networks Between Non-Cirrhotic HCC and Cirrhotic HCC.

Multi-omics-driven Discovery of Invasive Patterns and Treatment Strategies in CA19-9 Positive Intrahepatic Cholangiocarcinoma

Integrated Analysis of Differentially Expressed Mrnas and Mirnas Between Hepatocellular Carcinoma and Their Matched Adjacent Normal Liver Tissues